Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.200
-0.010 (-0.83%)
May 13, 2025, 4:00 PM - Market closed
Ventyx Biosciences Employees
As of December 31, 2024, Ventyx Biosciences had 82 total employees, including 79 full-time and 3 part-time employees. The number of employees increased by 2 or 2.50% compared to the previous year.
Employees
82
Change (1Y)
2
Growth (1Y)
2.50%
Revenue / Employee
n/a
Profits / Employee
-$1,512,073
Market Cap
85.39M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82 | 2 | 2.50% |
Dec 31, 2023 | 80 | 21 | 35.59% |
Dec 31, 2022 | 59 | 32 | 118.52% |
Dec 31, 2021 | 27 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VTYX News
- 5 days ago - Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress - GlobeNewsWire
- 6 weeks ago - Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists - GlobeNewsWire
- 2 months ago - Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress - GlobeNewsWire
- 3 months ago - Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn's Disease at ECCO 2025 - GlobeNewsWire
- 3 months ago - Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 4 months ago - Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio - GlobeNewsWire
- 6 months ago - Ventyx Biosciences to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Ventyx Biosciences: Ready To Escape "The Crash Cycle" - Seeking Alpha